Get Premium to unlock powerful stock data

Fate Therapeutics Inc (FATE) President and CEO J Scott Wolchko Sold $1.8 million of Shares

Author's Avatar
insider
Dec 18, 2020
Article's Main Image

President and CEO of Fate Therapeutics Inc (30-Year Financial, Insider Trades) J Scott Wolchko (insider trades) sold 20,000 shares of FATE on 12/17/2020 at an average price of $91.82 a share. The total sale was $1.8 million.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. Fate Therapeutics Inc has a market cap of $8.07 billion; its shares were traded at around $92.450000 with and P/S ratio of 409.07. GuruFocus has detected 3 severe warning signs with Fate Therapeutics Inc. .

CEO Recent Trades:

  • President and CEO J Scott Wolchko sold 20,000 shares of FATE stock on 12/17/2020 at the average price of $91.82. The price of the stock has increased by 0.69% since.

Directors and Officers Recent Trades:

  • Chief Development Officer Bahram Valamehr sold 25,000 shares of FATE stock on 12/14/2020 at the average price of $97.78. The price of the stock has decreased by 5.45% since.

For the complete insider trading history of FATE, click here

.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Rating:
0 / 5 (0 votes)

Please Login to leave a comment

Author's Avatar

insider